GlobeImmune Inc (GBIM)
0.00
USD |
OTCM |
May 07, 16:00
GlobeImmune Total Assets (Quarterly): 9.771M for March 31, 2016
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2016 | 9.771M |
| December 31, 2015 | 11.51M |
| September 30, 2015 | 13.21M |
| June 30, 2015 | 13.54M |
| March 31, 2015 | 15.44M |
| December 31, 2014 | 18.37M |
| Date | Value |
|---|---|
| September 30, 2014 | 20.66M |
| June 30, 2014 | 10.21M |
| March 31, 2014 | 12.09M |
| December 31, 2013 | 7.418M |
| June 30, 2012 | 10.04M |
| March 31, 2012 | 13.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.621M |
| Shareholders Equity (Quarterly) | 2.150M |